Gaurav Chopra
Gaurav Chopra
Assistant Professor, Purdue University; Previous: UCSF, Stanford University
purdue.edu üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
CD28 costimulation: from mechanism to therapy
JH Esensten, YA Helou, G Chopra, A Weiss, JA Bluestone
Immunity 44 (5), 973-988, 2016
3572016
The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation
M DuPage, G Chopra, J Quiros, WL Rosenthal, MM Morar, D Holohan, ...
Immunity 42 (2), 227-238, 2015
1742015
KoBaMIN: a knowledge-based minimization web server for protein structure refinement
JP Rodrigues, M Levitt, G Chopra
Nucleic acids research 40 (W1), W323-W328, 2012
1492012
Divergent phenotypes of human regulatory T cells expressing the receptors TIGIT and CD226
CA Fuhrman, WI Yeh, HR Seay, PS Lakshmi, G Chopra, L Zhang, ...
The Journal of Immunology 195 (1), 145-155, 2015
1392015
Solvent dramatically affects protein structure refinement
G Chopra, CM Summa, M Levitt
Proceedings of the National Academy of Sciences 105 (51), 20239-20244, 2008
1142008
WeFold: a coopetition for protein structure prediction
GA Khoury, A Liwo, F Khatib, H Zhou, G Chopra, J Bacardit, LO Bortot, ...
Proteins: Structure, Function, and Bioinformatics 82 (9), 1850-1868, 2014
642014
Consistent refinement of submitted models at CASP using a knowledge‐based potential
G Chopra, N Kalisman, M Levitt
Proteins: Structure, Function, and Bioinformatics 78 (12), 2668-2678, 2010
612010
CANDO and the infinite drug discovery frontier
M Minie, G Chopra, G Sethi, J Horst, G White, A Roy, K Hatti, R Samudrala
Drug discovery today 19 (9), 1353-1363, 2014
452014
Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1
ZA Ali, V de Jesus Perez, K Yuan, M Orcholski, S Pan, W Qi, G Chopra, ...
The Journal of clinical investigation 124 (12), 5159-5174, 2014
402014
Exploring polypharmacology in drug discovery and repurposing using the CANDO platform
G Chopra, R Samudrala
Current pharmaceutical design 22 (21), 3109-3123, 2016
322016
Inhibition of 12/15-lipoxygenase protects against β-cell oxidative stress and glycemic deterioration in mouse models of type 1 diabetes
M Hernandez-Perez, G Chopra, J Fine, AM Conteh, RM Anderson, ...
Diabetes 66 (11), 2875-2887, 2017
282017
CANDOCK: Chemical atomic network-based hierarchical flexible docking algorithm using generalized statistical potentials
J Fine, J Konc, R Samudrala, G Chopra
Journal of chemical information and modeling 60 (3), 1509-1527, 2020
272020
Remarkable patterns of surface water ordering around polarized buckminsterfullerene
G Chopra, M Levitt
Proceedings of the National Academy of Sciences 108 (35), 14455-14460, 2011
272011
Combating ebola with repurposed therapeutics using the CANDO platform
G Chopra, S Kaushik, PL Elkin, R Samudrala
Molecules 21 (12), 1537, 2016
262016
Strategic protein target analysis for developing drugs to stop dental caries
JA Horst, U Pieper, A Sali, L Zhan, G Chopra, R Samudrala, ...
Advances in dental research 24 (2), 86-93, 2012
262012
Multiscale modelling of relationships between protein classes and drug behavior across all diseases using the CANDO platform
G Sethi, G Chopra, R Samudrala
Mini reviews in medicinal chemistry 15 (8), 705-717, 2015
192015
An analysis and evaluation of the WeFold collaborative for protein structure prediction and its pipelines in CASP11 and CASP12
C Keasar, LJ McGuffin, B Wallner, G Chopra, B Adhikari, D Bhattacharya, ...
Scientific reports 8 (1), 1-18, 2018
172018
Integrated pan-cancer map of EBV-associated neoplasms reveals functional host–virus interactions
S Chakravorty, B Yan, C Wang, L Wang, JT Quaid, CF Lin, SD Briggs, ...
Cancer research 79 (23), 6010-6023, 2019
152019
Identification of new FLT3 inhibitors that potently inhibit AML cell lines via an azo click-it/staple-it approach
X Ma, J Zhou, C Wang, B Carter-Cooper, F Yang, E Larocque, J Fine, ...
ACS medicinal chemistry letters 8 (5), 492-497, 2017
152017
Aminoisoquinoline benzamides, FLT3 and Src-family kinase inhibitors, potently inhibit proliferation of acute myeloid leukemia cell lines
E Larocque, N Naganna, X Ma, C Opoku-Temeng, B Carter-Cooper, ...
Future medicinal chemistry 9 (11), 1213-1225, 2017
142017
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20